PET tracer 4DST beats FDG for imaging cancer proliferation

March 8, 2012

A Japanese study highlights the benefits of a new PET radiotracer for imaging the proliferation of cancer cells in non-small cell lung cancer (NSCLC), as compared with PET's workhorse radiopharmaceutical, FDG. The new tracer may also help noninvasively reveal the DNA synthesis of NSCLC cells.